Rayner Intraocular Lenses Limited
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Aug 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 5, 2027The maintenance fee for Multifocal lens (US 10,463,474) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
- 1 fee due Jul 7, 2027The maintenance fee for Multifocal lens and method for producing same (US 10,524,899) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Aug 25 US 12,714,553 Intraocular Lens with Focal Performance Tailored to Pupil Size Deploying Refractive Power Modification Along Spiral Tracks
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,572,658 | Intraocular lens cartridge In force · USPTO record | In force | USPTO record | |
| US 9,066,856 | Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection In force · High confidence | In force | High confidence | |
| US 9,486,406 | Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection In force · Medium confidence | In force | Medium confidence | |
| US 9,855,246 | Stable Preservative-Free Mydriatic and Anti-Inflammatory Solutions for Injection In force · Medium confidence | In force | Medium confidence | |
| US 12,133,842 | Stable Preservative-Free Mydriatic and Anti-Inflammatory Solutions for Injection In force · Low confidence | In force | Low confidence | |
| US 11,234,965 | Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions In force · High confidence | In force | High confidence | |
| US 12,167,999 | Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions In force · High confidence | In force | High confidence | |
| US 10,463,474 | Multifocal lens In force · USPTO record | In force | USPTO record | |
| US 10,524,899 | Multifocal lens and method for producing same In force · USPTO record | In force | USPTO record | |
| US 11,029,536 | Multifocal lens In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 11: 5 patents in force now held by others · 4 lapsed for an unpaid fee · 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 3 no status recorded